NCT04307381 - An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

January 24, 2025

Study Completion Date

January 24, 2025

Conditions

Hereditary Angioedema

Interventions

DRUG

Donidalorsen

Donidalorsen administered SC

Trial Locations (7)

Ionis Investigative Site, Hershey

Ionis Investigative Site, Cincinnati

Ionis Investigative Site, Plymouth

Ionis Investigative Site, Dallas

Ionis Investigative Site, Scottsdale

Ionis Investigative Site, Santa Monica

Ionis Investigative Site, Amsterdam